Nisa Investment Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $25.3K | Buy |
2,822
+34
| +1% | +$305 | ﹤0.01% | 1828 |
|
2025
Q1 | $20.9K | Buy |
2,788
+294
| +12% | +$2.21K | ﹤0.01% | 1854 |
|
2024
Q4 | $18.8K | Sell |
2,494
-75
| -3% | -$564 | ﹤0.01% | 1955 |
|
2024
Q3 | $19.5K | Buy |
2,569
+476
| +23% | +$3.62K | ﹤0.01% | 1916 |
|
2024
Q2 | $12.9K | Buy |
2,093
+3
| +0.1% | +$19 | ﹤0.01% | 2071 |
|
2024
Q1 | $10.6K | Buy |
2,090
+180
| +9% | +$914 | ﹤0.01% | 2026 |
|
2023
Q4 | $11.4K | Sell |
1,910
-3,415
| -64% | -$20.5K | ﹤0.01% | 2014 |
|
2023
Q3 | $37.7K | Buy |
5,325
+34
| +0.6% | +$241 | ﹤0.01% | 1812 |
|
2023
Q2 | $37.2K | Buy |
5,291
+3,371
| +176% | +$23.7K | ﹤0.01% | 1852 |
|
2023
Q1 | $16K | Sell |
1,920
-4,430
| -70% | -$36.9K | ﹤0.01% | 2064 |
|
2022
Q4 | $73K | Buy |
6,350
+11
| +0.2% | +$126 | ﹤0.01% | 1658 |
|
2022
Q3 | $85K | Buy |
6,339
+129
| +2% | +$1.73K | ﹤0.01% | 1559 |
|
2022
Q2 | $66K | Hold |
6,210
| – | – | ﹤0.01% | 1638 |
|
2022
Q1 | $101K | Sell |
6,210
-730
| -11% | -$11.9K | ﹤0.01% | 1612 |
|
2021
Q4 | $107K | Sell |
6,940
-4,560
| -40% | -$70.3K | ﹤0.01% | 1493 |
|
2021
Q3 | $165 | Hold |
11,500
| – | – | ﹤0.01% | 1481 |
|
2021
Q2 | $182 | Sell |
11,500
-425
| -4% | -$7 | ﹤0.01% | 1441 |
|
2021
Q1 | $121 | Buy |
11,925
+9,000
| +308% | +$91 | ﹤0.01% | 1667 |
|
2020
Q4 | $22K | Buy |
2,925
+850
| +41% | +$6.39K | ﹤0.01% | 2103 |
|
2020
Q3 | $7K | Hold |
2,075
| – | – | ﹤0.01% | 2160 |
|
2020
Q2 | $10K | Buy |
2,075
+105
| +5% | +$506 | ﹤0.01% | 1916 |
|
2020
Q1 | $4K | Buy |
+1,970
| New | +$4K | ﹤0.01% | 1968 |
|
2017
Q2 | – | Sell |
-1,000
| Closed | -$8K | – | 1837 |
|
2017
Q1 | $8K | Buy |
+1,000
| New | +$8K | ﹤0.01% | 1724 |
|
2016
Q2 | – | Sell |
-2,600
| Closed | -$7K | – | 1861 |
|
2016
Q1 | $7K | Buy |
+2,600
| New | +$7K | ﹤0.01% | 1814 |
|